Faculty

Dr Yasuhiro Fujiwara is Chief Executive of the Pharmaceuticals and Medical Devices Agency (PMDA) since 2019. He actively engages with international regulatory agencies, including the International Coalition of Medicines Regulatory Authorities (ICMRA) in which he served as vice-chair 2019 to 2025. Under his strong leadership, PMDA has promoted collaboration with Asian regulatory authorities.

A medical oncologist specializing in breast cancer, Dr Fujiwara was previously Director-General of the Strategic Planning Bureau of the National Cancer Center, and Deputy Director of National Cancer Center Hospital. Between Jan 2011 to Feb 2013, he was a Deputy Secretary General of the Office of Medical Innovation, Cabinet Secretariat of Japan, and led health policy issues regarding life science.

Dr Fujiwara has authored or co-authored over 280 original articles in peer-reviewed journals. He is an active member of the American Society of Clinical Oncology and serves on the editorial board of some journals.